Assembly BillIntroduced
A 2156: Relates to medical assistance for patients in the process of oral or injectable ovulation enhancing drugs.
What A 2156 does, verified January 8, 2026
The bill aims to improve health outcomes for women taking oral or injectable ovulation enhancing drugs. It will cover a set of services, including treatment, office visits, and diagnostic tests such as hysterosalpingograms, pelvic ultrasounds, and blood tests. These services will be limited to those necessary to monitor the treatment. In the absence of federal funding, the state will use its share of appropriations to establish a grant program to achieve the bill's purpose. The bill will take effect 90 days after it becomes a law.
Bill journey
1IntroducedCurrent
2In CommitteePending
3First Chamber FloorPending
4Second ChamberPending
5GovernorPending
6ChapteredPending
Last action: referred to health (2026-01-07)Alert me
Quick answers about A 2156
- What is the current status of A 2156?
- As of January 8, 2026, A 2156 is recorded as "Introduced": it has been introduced and is waiting for its first committee hearing or floor vote. The last recorded action, on January 7, 2026, was "referred to health".
- Did A 2156 pass?
- Not yet. A 2156 has been introduced and has not passed either house.
- Who wrote A 2156, and where is it now?
- A 2156 was authored by Asm. Amy Paulin with 1 coauthor. Its committee of record is Assembly Health.
Author and sponsors
Full contact details, staff, and committees with Connect, $16/moUnlockRecent actions2 total · showing 2
| Jan. 07, 2026 | referred to health |
| Jan. 15, 2025 | referred to health |
Latest bill textIntroduced version, January 15, 2025 · 269 words
STATE OF NEW YORK ________________________________________________________________________ 2156 2025-2026 Regular Sessions IN ASSEMBLY January 15, 2025 ___________ Introduced by M. of A. PAULIN, SAYEGH -- read once and referred to the Committee on Health AN ACT to amend the social services law, in relation to medical assist- ance for patients in the process of oral or injectable ovulation enhancing drugs The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Paragraph (ee) of subdivision 2 of section 365-a of the 2 social services law, as added by section 4 of part S of chapter 57 of 3 the laws of 2017, is amended to read as follows: 4 (ee) Medical assistance shall include the coverage of a set of 5 services to ensure improved outcomes of [women] patients who are in the 6 process of oral or injectable ovulation enhancing drugs, limited to the 7 provision of such treatment, office visits, hysterosalpingogram 8 services, pelvic ultrasounds, and blood testing; services shall be 9 limited to those necessary to monitor such treatment. In the event that 10 ninety percent federal financial participation for such services is not 11 available, the state share of appropriations related to these services 12 shall be used for a grant program intended to accomplish the purpose of 13 this section. 14 § 2. This act shall take effect on the ninetieth day after it shall 15 have become a law. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [] is old law to be omitted. LBD05352-01-5
Text of A 2156 as introduced, from the official record. Connect Plus keeps every version and highlights what changed.Compare versions